Recent Updates on Synthesis, Biological Activity, and Structure-activity Relationship of 1,3,4-Oxadiazole-quinoline Hybrids: A Review

Curr Org Synth. 2023;20(7):758-787. doi: 10.2174/1570179420666221004142659.

Abstract

Due to their diverse applications in industrial and synthetic organic chemistry, quinoline and 1,3,4-oxadiazole have become important heterocyclic compounds. Quinoline and 1,3,4- oxadiazole compounds have been developed for various medical conditions such as anti-cancer, anti-bacterial, anti-fungal, antimalarial, antioxidants, anti-HIV, anticonvulsant, antiviral, etc. The current review includes synthetic protocols for biologically active 1,3,4-oxadiazole incorporating quinoline hybrids with their structure-activity relationship to explore work (Mainly from 2010 to 2021) based on 1,3,4-oxadiazole-quinoline hybrids to the medicinal chemist for further research in the development of the molecule.

Keywords: Oxadiazole; biological activity; oxadiazole-quinoline hybrids; quinoline; structure-activity relationship; synthetic approaches.

Publication types

  • Review

MeSH terms

  • Antimalarials* / chemistry
  • Antimalarials* / pharmacology
  • Oxadiazoles / chemistry
  • Oxadiazoles / pharmacology
  • Quinolines*
  • Structure-Activity Relationship

Substances

  • 1,3,4-oxadiazole
  • Antimalarials
  • Oxadiazoles
  • Quinolines